Therefore, PDGFRβ signaling and associated changes in miRNA expression may be involved in the development of chronic inflammation and fibrosis as well as subsequent tumorigenesis during the development of diabetic MASH. The gene discussed is PDGFRB; the disease is metabolic dysfunction-associated steatohepatitis.